CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing

Stock Information for VBI Vaccines Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About VBI Vaccines Inc.

CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live
CNS Pharmaceuticals Announces Reverse Stock Split
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.